Preclinical mouse models showed that IL13Rα2 CAR T could cause regression of adult glioma patient-derived xenografts (PDX), including tumours derived from intracranial injection of a stem-cell enriched population (20). This evidence concerns the gene IL13RA2 and neoplasm.